Potential challenges to sustained viral load suppression in the HIV treatment programme in South Africa: a narrative overview

[1] Cohen MS(2011)Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 493-505

[2] Chen YQ(2013)High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa Science (80-). 339 966-971

[3] McCauley M(2008)Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004 Antivir Ther 13 101-107

[4] Gamble T(2012)Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009 Clin Infect Dis 54 S334-S338

[5] Hosseinipour MC(2016)Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the First South African National Survey PLoS ONE 11 e0166305-210

[6] Kumarasamy N(2019)Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods Antivir Ther 24 203-34

[7] Tanser F(2019)Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis EClinicalMedicine 9 26-309

[8] Bärnighausen T(2011)Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa J Health Popul Nutr 29 303-565

[9] Grapsa E(2012)Primary drug resistance in South Africa: data from 10 years of surveys AIDS Res Hum Retroviruses 28 558-1513

[10] Zaidi J(2011)Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa J Med Virol 83 1508-214

[1] Cohen MS(2011)Prevention of HIV-1 infection with early antiretroviral therapy N Engl J Med 365 493-505

[2] Chen YQ(2013)High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa Science (80-). 339 966-971

[3] McCauley M(2008)Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004 Antivir Ther 13 101-107

[4] Gamble T(2012)Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005–2009 Clin Infect Dis 54 S334-S338

[5] Hosseinipour MC(2016)Moderate levels of pre-treatment HIV-1 antiretroviral drug resistance detected in the First South African National Survey PLoS ONE 11 e0166305-210

[6] Kumarasamy N(2019)Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods Antivir Ther 24 203-34

[7] Tanser F(2019)Trends in pretreatment HIV-1 drug resistance in antiretroviral therapy-naive adults in South Africa, 2000–2016: a pooled sequence analysis EClinicalMedicine 9 26-309

[8] Bärnighausen T(2011)Prevalence of antiretroviral drug resistance mutations and HIV-I subtypes among newly-diagnosed drug-naive persons visiting a voluntary testing and counselling centre in northeastern South Africa J Health Popul Nutr 29 303-565

[9] Grapsa E(2012)Primary drug resistance in South Africa: data from 10 years of surveys AIDS Res Hum Retroviruses 28 558-1513

[10] Zaidi J(2011)Resistance to antiretroviral drugs in newly diagnosed, young treatment-naive HIV-positive pregnant women in the province of KwaZulu-Natal, South Africa J Med Virol 83 1508-214